A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
Substances that reduce the growth or reproduction of BACTERIA.
A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties.
An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
A genus of gram-positive bacteria whose spores are round to oval and covered by a sheath.
An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections.
Compounds based on ERYTHROMYCIN with the 3-cladinose replaced by a ketone. They bind the 23S part of 70S bacterial RIBOSOMES.
A macrolide antibiotic from Streptomyces narbonensis. The drug has antimicrobial activity against a wide spectrum of pathogens.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.
A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Infections with bacteria of the genus STREPTOCOCCUS.
A macrolide antibiotic that has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections.
A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.
A family of LINCOMYCIN-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety. Individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule. Many lincosamides are ANTIBIOTICS produced by a variety STREPTOMYCES species.
A peptide of about 22-amino acids isolated from the DUODENUM. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect.
Antibiotic macrolide produced by Streptomyces antibioticus.
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
A macrolide antibiotic that is similar to ERYTHROMYCIN.
A species of gram-negative, rod-shaped bacteria isolated from the intestinal tract of swine, poultry, and man. It may be pathogenic.
Nonsusceptibility of bacteria to the action of TETRACYCLINE which inhibits aminoacyl-tRNA binding to the 30S ribosomal subunit during protein synthesis.
The evacuation of food from the stomach into the duodenum.
Nonsusceptibility of an organism to the action of penicillins.
A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1.
Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.
A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Deoxyribonucleic acid that makes up the genetic material of bacteria.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Proteins found in any species of bacterium.
Constituent of 50S subunit of prokaryotic ribosomes containing about 3200 nucleotides. 23S rRNA is involved in the initiation of polypeptide synthesis.
The functional hereditary units of BACTERIA.
A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
A bacterium which causes mastitis in cattle and occasionally in man.
Gram-negative aerobic rods, isolated from surface water or thermally polluted lakes or streams. Member are pathogenic for man. Legionella pneumophila is the causative agent for LEGIONNAIRES' DISEASE.
A cytochrome P-450 suptype that has specificity for a broad variety of lipophilic compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN.
A genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic.
Macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans.
A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation.
Multicomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION.
Infections with bacteria of the genus STAPHYLOCOCCUS.
The motor activity of the GASTROINTESTINAL TRACT.
A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic.
A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals.
Process of determining and distinguishing species of bacteria or viruses based on antigens they share.
A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate EUKARYOTA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.
Inflammation of the throat (PHARYNX).
An acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache. It is named for an outbreak at the 1976 Philadelphia convention of the American Legion.

Physiological role of the N-terminal processed P4501A1 targeted to mitochondria in erythromycin metabolism and reversal of erythromycin-mediated inhibition of mitochondrial protein synthesis. (1/2077)

Recently, we showed that the major species of beta-naphthoflavone-inducible rat liver mitochondrial P450MT2 consists of N-terminal truncated microsomal P4501A1 (+33/1A1) and that the truncated enzyme exhibits different substrate specificity as compared with intact P4501A1. The results of the present study show that P450MT2 targeted to COS cell mitochondria by transient transfection of P4501A1 cDNA is localized inside the mitochondrial inner membrane in a membrane-extrinsic orientation. Co-expression with wild type P4501A1 and adrenodoxin (Adx) cDNAs resulted in 5-7-fold higher erythromycin N-demethylation (ERND) in the mitochondrial fraction but minimal changes in the microsomal fraction of transfected cells. Erythromycin, a potent inhibitor of bacterial and mitochondrial protein synthesis, caused 8-12-fold higher accumulation of CYP1A1 mRNA, preferential accumulation of P450MT2, and 5-6-fold higher ERND activity in the mitochondrial compartment of rat C6 glioma cells. Consistent with the increased mitochondrial ERND activity, co-expression with P4501A1 and Adx in COS cells rendered complete protection against erythromycin-mediated mitochondrial translation inhibition. Mutations that specifically affect the mitochondrial targeting of P4501A1 also abolished protection against mitochondrial translation inhibition. These results for the first time suggest a physiological function for the xenobiotic inducible cytochrome P4501A1 against drug-mediated mitochondrial toxicity.  (+info)

Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products. (2/2077)

The structures of complex polyketide natural products, such as erythromycin, are programmed by multifunctional polyketide synthases (PKSs) that contain modular arrangements of functional domains. The colinearity between the activities of modular PKS domains and structure of the polyketide product portends the generation of novel organic compounds-"unnatural" natural products-by genetic manipulation. We have engineered the erythromycin polyketide synthase genes to effect combinatorial alterations of catalytic activities in the biosynthetic pathway, generating a library of >50 macrolides that would be impractical to produce by chemical methods. The library includes examples of analogs with one, two, and three altered carbon centers of the polyketide products. The manipulation of multiple biosynthetic steps in a PKS is an important milestone toward the goal of producing large libraries of unnatural natural products for biological and pharmaceutical applications.  (+info)

Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. (3/2077)

The susceptibility of 40 erythromycin-resistant isolates of Streptococcus pyogenes and 40 multiply-resistant isolates of Streptococcus pneumoniae to six macrolide antibiotics, representing 14-, 15- and 16-membered lactone ring structures, was tested. The genetic basis for macrolide resistance in the strains was also determined. Both erm and mef determinants were encountered in the 36 S. pneumoniae isolates tested, but only mef in the five S. pyogenes isolates tested. All isolates showed cross-resistance among the 14-membered macrolides erythromycin, clarithromycin and roxithromycin and the 15-membered macrolide, azithromycin. However, the erythromycin-resistant S. pyogenes isolates retained full susceptibility to spiramycin and josamycin (16-membered agents). These latter two antibiotics were also more active than the other macrolides against erythromycin-resistant S. pneumoniae isolates, especially josamycin which was 8-64 times more active than erythromycin; spiramycin was only two to eight times more active than erythromycin.  (+info)

A pilot study of low-dose erythromycin in bronchiectasis. (4/2077)

Patients with bronchiectasis suffer from sputum production, recurrent exacerbations, and progressive airway destruction. Erythromycin is effective in diffuse panbronchiolitis, another suppurative airway disorder, although its efficacy is unknown in idiopathic bronchiectasis. A double-blind placebo-controlled study was therefore conducted to evaluate the effects of 8-week administration of low dose erythromycin (500 mg b.i.d.) in steady-state idiopathic bronchiectasis. Patients in the erythromycin group (n=11, 8 female, mean age 50+/-15 yrs), but not the placebo group (n=10, 8 female, mean age 59+/-16 yrs) had significantly improved forced expiratory volume in one second, forced vital capacity and 24-h sputum volume after 8 weeks (p<0.05). There was no parallel improvement in sputum pathogens, leukocytes, interleukin (IL)-1alpha and IL-8, tumour necrosis factor-alpha, or leukotriene B4. The results of this pilot study show that low-dose erythromycin improves lung function and sputum volume in bronchiectasis. Further studies are indicated to evaluate the efficacy of long-term erythromycin therapy in bronchiectasis.  (+info)

Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. (5/2077)

From January 1996 to December 1997, 200 isolates of Streptococcus pneumoniae recovered from 200 patients treated at National Taiwan University Hospital were serotyped and their susceptibilities to 16 antimicrobial agents were determined by the agar dilution method. Sixty-one percent of the isolates were nonsusceptible to penicillin, exhibiting either intermediate resistance (28%) or high-level resistance (33%). About two-fifths of the isolates displayed intermediate or high-level resistance to cefotaxime, ceftriaxone, cefepime, imipenem, and meropenem. Extremely high proportions of the isolates were resistant to erythromycin (82%), clarithromycin (90%), and trimethoprim-sulfamethoxazole (TMP-SMZ) (87%). Among the isolates nonsusceptible to penicillin, 23.8% were resistant to imipenem; more than 60% displayed resistance to cefotaxime, ceftriaxone, cefepime, and carbapenems; 96.7% were resistant to erythromycin; and 100% were resistant to TMP-SMZ. All isolates were susceptible to rifampin and vancomycin. The MICs at which 50% and 90% of the isolates were inhibited were 0.12 and 1 microgram/ml, respectively, for cefpirome, and 0.12 and 0.25 microgram/ml, respectively, for moxifloxacin. Six serogroups or serotypes (23F, 19F, 6B, 14, 3, and 9) accounted for 77.5% of all isolates. Overall, 92.5% of the isolates were included in the serogroups or serotypes represented in the 23-valent pneumococcal vaccine. The incidence of macrolide and TMP-SMZ resistance for S. pneumoniae isolates in Taiwan in this study is among the highest in the world published to date.  (+info)

Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute. (6/2077)

OBJECTIVE: To determine whether early postoperative administration of erythromycin accelerates the spontaneous motor recovery process after elevation of the denervated whole stomach up to the neck. SUMMARY BACKGROUND DATA: Spontaneous motor recovery after gastric denervation is a slow process that progressively takes place over years. METHODS: Erythromycin was administered as follows: continuous intravenous (i.v.) perfusion until postoperative day 10 in ten whole stomach (WS) patients at a dose of either 1 g (n = 5) or 2 g (n = 5) per day; oral intake at a dose of 1 g/day during 1.5 to 8 months after surgery in 11 WS patients, followed in 7 of them by discontinuation of the drug during 2 to 4 weeks. Gastric motility was assessed with intraluminal perfused catheters in these 21 patients, in 23 WS patients not receiving erythromycin, and in 11 healthy volunteers. A motility index was established by dividing the sum of the areas under the curves of >9 mmHg contractions by the time of recording. RESULTS: The motility index after IV or oral administration of erythromycin at and after surgery was significantly higher than that without erythromycin (i.v., 1 g: p = 0.0090; i.v., 2 g: p = 0.0090; oral, 1 g: p = 0.0017). It was similar to that in healthy volunteers (i.v., 1 g: p = 0.2818; oral, 1 g: p = 0.7179) and to that in WS patients with >3 years of follow-up who never received erythromycin (i.v., 1 g: p = 0.2206; oral, 1 g: p = 0.8326). The motility index after discontinuation of the drug was similar or superior to that recorded under medication in four patients who did not experience any modification of their alimentary comfort, whereas it dropped dramatically parallel to deterioration of the alimentary comfort in three patients. CONCLUSIONS: Early postoperative contractility of the denervated whole stomach pulled up to the neck under either i.v. or oral erythromycin is similar to that recovered spontaneously beyond 3 years of follow-up. In some patients, this booster effect persists after discontinuation of the drug.  (+info)

Effect of cyclosporine A on cytochrome P-450-mediated drug metabolism in the partially hepatectomized rat. (7/2077)

Despite its hepatotoxic potential, cyclosporine A (CsA) has been reported to positively influence compensatory liver growth. To probe the physiological consequences of CsA on the recovery of liver function, studies were initiated in the 2/3 partially hepatectomized (PHx) rat, taking the recovery of cytochromes P-450-dependent drug metabolism as primary outcome. CsA was administered at a dose of 3. 33 mg/kg/day for 10 days. Drug metabolism was evaluated by the recovery of 14CO2 after administration of isotopically labeled model drugs and by studying the expression of the P-450 transcripts involved in their biotransformation before and 24 to 96 h after PHx. Before PHx, neither the steady-state mRNA nor the in vivo disposition of caffeine (CYP1A2), erythromycin (CYP3A2 and 3A1), or aminopyrine (CYP2B1 and 2C11) were influenced by CsA. Studies 24 h after PHx revealed a 29 to 39% reduction in the elimination of [14C]aminopyrine and [14C]erythromycin, which was unaffected by CsA. Their metabolism at 48 to 96 h after PHx also remained unaffected by CsA. By contrast, postPHx, [14C]caffeine elimination decreased to a level closely proportional to the loss in liver mass. In addition, CsA accelerated the recovery and/or prevented the decrease of caffeine elimination 24 h after PHx but not at later time points, indicating an early, but unsustained, beneficial effect of CsA on the recovery of CYP1A2-mediated activities. These data show that at the critical time of greatest loss in liver mass, CsA has only a selective influence on the biotransformation of cytochrome P-450 protein-dependent activities and that its effect on the regeneration process does not translate into an overall accelerated recovery of the hepatic drug-metabolizing function.  (+info)

Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. (8/2077)

Macrolide antibiotics such as erythromycin have been reported to be effective for asthma. However, the precise mechanisms of this effect remain unclear. We studied the effect of erythromycin, clarithromycin, josamycin, and other antibiotics on the release by eosinophils of interleukin-8 (IL-8), a potent chemokine for inflammatory cells, including eosinophils themselves. Human eosinophils were isolated from atopic patients, and the effects of the drugs on IL-8 release were evaluated. Only 14-member macrolides (erythromycin and clarithromycin) showed a concentration-dependent suppressive effect on IL-8 release (control, 100%; erythromycin at 1 microgram/ml, 67.82% +/- 3.45% [P < 0.01]; clarithromycin at 5 micrograms/ml, 56.81% +/- 9.61% [P < 0.01]). The effect was found at therapeutic concentrations and appeared to occur at the posttranscriprtional level. In contrast, a 16-member macrolide (josamycin) had no significant effect. We suggest that 14-member macrolides inhibit IL-8 release by eosinophils and may thereby prevent the autocrine cycle necessary for the recruitment of these cells into the airways.  (+info)

Erythromycin is a type of antibiotic known as a macrolide, which is used to treat various types of bacterial infections. It works by inhibiting the bacteria's ability to produce proteins, which are necessary for the bacteria to survive and multiply. Erythromycin is often used to treat respiratory tract infections, skin infections, and sexually transmitted diseases. It may also be used to prevent endocarditis (inflammation of the lining of the heart) in people at risk of this condition.

Erythromycin is generally considered safe for most people, but it can cause side effects such as nausea, vomiting, and diarrhea. It may also interact with other medications, so it's important to tell your doctor about all the drugs you are taking before starting erythromycin.

Like all antibiotics, erythromycin should only be used to treat bacterial infections, as it is not effective against viral infections such as the common cold or flu. Overuse of antibiotics can lead to antibiotic resistance, which makes it harder to treat infections in the future.

Erythromycin Estolate is a type of antibiotic that belongs to the macrolide class. It is a formulation of erythromycin, an antibiotic produced naturally by the bacterium Saccharopolyspora erythraea, which is combined with estolic acid, a type of fatty acid, to create a stable salt. This medication works by inhibiting protein synthesis in bacteria, which helps to stop the growth and multiplication of harmful bacteria in the body.

Erythromycin Estolate is commonly used to treat a variety of bacterial infections, including respiratory tract infections, skin infections, and sexually transmitted diseases. It is also sometimes used as an alternative treatment for people who are allergic to penicillin or other antibiotics.

Like all medications, Erythromycin Estolate can have side effects, including stomach upset, diarrhea, and skin rashes. In rare cases, it may cause more serious side effects such as liver damage or hearing loss. It is important to follow the instructions of a healthcare provider when taking this medication and to report any unusual symptoms or side effects promptly.

Erythromycin Ethylsuccinate is a type of antibiotic that belongs to the macrolide class. It is a formulation of erythromycin, an antibiotic produced naturally by the bacterium Saccharopolyspora erythraea, which has been chemically modified by combining it with succinic acid and ethyl alcohol. This results in a more soluble and stable form of erythromycin that is better suited for oral administration.

Erythromycin Ethylsuccinate works by inhibiting bacterial protein synthesis, which prevents the bacteria from growing and multiplying. It is effective against a wide range of gram-positive and gram-negative bacteria, making it a useful antibiotic for treating various types of infections, such as respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases.

Like all antibiotics, Erythromycin Ethylsuccinate should be used only under the direction of a healthcare professional, as misuse can lead to antibiotic resistance and other complications. It is important to follow the dosage instructions carefully and complete the full course of treatment, even if symptoms improve before the medication is finished.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Macrolides are a class of antibiotics derived from natural products obtained from various species of Streptomyces bacteria. They have a large ring structure consisting of 12, 14, or 15 atoms, to which one or more sugar molecules are attached. Macrolides inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing peptide bond formation. Common examples of macrolides include erythromycin, azithromycin, and clarithromycin. They are primarily used to treat respiratory, skin, and soft tissue infections caused by susceptible gram-positive and gram-negative bacteria.

Leucomycins are a type of antibiotic produced by the bacterium Streptomyces kitasatoensis. They are known to be effective against a wide range of gram-positive bacteria, including some that are resistant to other antibiotics. Leucomycins belong to a class of antibiotics called aminoglycosides, which work by binding to the bacterial ribosome and inhibiting protein synthesis.

Leucomycin A, one of the components of leucomycins, has been studied for its potential anti-tumor properties. However, its use as a therapeutic agent is limited due to its toxicity and potential for causing hearing loss and kidney damage. Therefore, it is mainly used in research settings to study bacterial physiology and antibiotic resistance mechanisms.

Lincomycin is defined as an antibiotic produced by Streptomyces lincolnensis. It is primarily bacteriostatic, inhibiting protein synthesis in sensitive bacteria by binding to the 50S ribosomal subunit. Lincomycin is used clinically to treat a variety of infections caused by susceptible gram-positive organisms, including some anaerobes. It has activity against many strains of streptococci, pneumococci, and staphylococci, but not enterococci. Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

"Saccharopolyspora" is a genus of Gram-positive, aerobic bacteria that forms branched hyphae and spores. These bacteria are known for their ability to produce various bioactive compounds, including antibiotics and enzymes. They are commonly found in soil, water, and decaying vegetation. One species of this genus, Saccharopolyspora erythraea (formerly known as Actinomyces erythreus), is the source of the antibiotic erythromycin.

It's important to note that "Saccharopolyspora" is a taxonomic category used in bacterial classification, and individual species within this genus may have different characteristics and medical relevance. Some species of Saccharopolyspora can cause infections in humans, particularly in immunocompromised individuals, but these are relatively rare.

If you're looking for information on a specific species of Saccharopolyspora or its medical relevance, I would need more context to provide a more detailed answer.

Clindamycin is a antibiotic medication used to treat a variety of bacterial infections. It is a type of antibiotic known as a lincosamide, which works by binding to the bacterial ribosome and inhibiting protein synthesis. This leads to the death of the bacteria and helps to clear the infection.

Clindamycin is effective against a wide range of gram-positive and some anaerobic bacteria, making it a useful antibiotic for treating many different types of infections, including skin and soft tissue infections, bone and joint infections, respiratory infections, and dental infections. It is also sometimes used to treat certain types of bacterial vaginal infections.

Like all antibiotics, clindamycin should be used only under the direction of a healthcare provider, as misuse can lead to antibiotic resistance. Additionally, clindamycin can cause side effects such as diarrhea, nausea, and vomiting, and it may increase the risk of developing a serious intestinal infection called Clostridioides difficile-associated diarrhea (CDAD). It is important to follow your healthcare provider's instructions carefully when taking this medication.

Microbial drug resistance is a significant medical issue that refers to the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to withstand or survive exposure to drugs or medications designed to kill them or limit their growth. This phenomenon has become a major global health concern, particularly in the context of bacterial infections, where it is also known as antibiotic resistance.

Drug resistance arises due to genetic changes in microorganisms that enable them to modify or bypass the effects of antimicrobial agents. These genetic alterations can be caused by mutations or the acquisition of resistance genes through horizontal gene transfer. The resistant microbes then replicate and multiply, forming populations that are increasingly difficult to eradicate with conventional treatments.

The consequences of drug-resistant infections include increased morbidity, mortality, healthcare costs, and the potential for widespread outbreaks. Factors contributing to the emergence and spread of microbial drug resistance include the overuse or misuse of antimicrobials, poor infection control practices, and inadequate surveillance systems.

To address this challenge, it is crucial to promote prudent antibiotic use, strengthen infection prevention and control measures, develop new antimicrobial agents, and invest in research to better understand the mechanisms underlying drug resistance.

Azithromycin is a widely used antibiotic drug that belongs to the class of macrolides. It works by inhibiting bacterial protein synthesis, which leads to the death of susceptible bacteria. This medication is active against a broad range of gram-positive and gram-negative bacteria, atypical bacteria, and some parasites.

Azithromycin is commonly prescribed to treat various bacterial infections, such as:

1. Respiratory tract infections, including pneumonia, bronchitis, and sinusitis
2. Skin and soft tissue infections
3. Sexually transmitted diseases, like chlamydia
4. Otitis media (middle ear infection)
5. Traveler's diarrhea

The drug is available in various forms, including tablets, capsules, suspension, and intravenous solutions. The typical dosage for adults ranges from 250 mg to 500 mg per day, depending on the type and severity of the infection being treated.

Like other antibiotics, azithromycin should be used judiciously to prevent antibiotic resistance. It is essential to complete the full course of treatment as prescribed by a healthcare professional, even if symptoms improve before finishing the medication.

Roxithromycin is a macrolide antibiotic that is used to treat various types of bacterial infections, including respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases. It works by inhibiting the growth of bacteria by interfering with their protein synthesis.

Roxithromycin has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus, Moraxella catarrhalis, Mycoplasma pneumoniae, Chlamydia trachomatis, and Neisseria gonorrhoeae.

The drug is available in various forms, including tablets, capsules, and oral suspension, and is usually taken twice a day for 5-10 days, depending on the type and severity of the infection being treated. Common side effects of roxithromycin include nausea, diarrhea, abdominal pain, headache, and skin rash.

It's important to note that roxithromycin should only be used under the guidance of a healthcare professional, as with any medication, to ensure its safe and effective use.

Ketolides are a class of antibiotics, which are chemically modified versions of macrolide antibiotics. They have an extended spectrum of activity and improved stability against bacterial resistance mechanisms compared to older macrolides. Ketolides inhibit protein synthesis in bacteria by binding to the 50S ribosomal subunit.

The main ketolide antibiotics include telithromycin, cethromycin, and solithromycin. They are primarily used for treating respiratory tract infections caused by susceptible strains of bacteria, including drug-resistant pneumococci and atypical pathogens like Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydia pneumoniae.

It is important to note that ketolides have potential side effects, such as gastrointestinal disturbances, liver enzyme elevations, and cardiac arrhythmias, which should be considered when prescribing them.

Josamycin is an antibiotic that belongs to the group known as macrolides. It works by stopping the growth of bacteria. Josamycin is used to treat infections caused by bacteria, including respiratory tract infections, skin and soft tissue infections, and ear infections. It may also be used to prevent endocarditis (inflammation of the lining of the heart) in people at risk of developing this condition who are undergoing dental or surgical procedures.

Josamycin is not commonly used in the United States, and it is not approved for use in children. It is available in generic form as a tablet or oral suspension.

Like all antibiotics, josamycin should be used only to treat bacterial infections. It will not work against viral infections (such as the common cold or flu). Using antibiotics when they are not needed increases the risk of bacteria becoming resistant to them, which makes it harder to treat infections in the future.

Bacterial drug resistance is a type of antimicrobial resistance that occurs when bacteria evolve the ability to survive and reproduce in the presence of drugs (such as antibiotics) that would normally kill them or inhibit their growth. This can happen due to various mechanisms, including genetic mutations or the acquisition of resistance genes from other bacteria.

As a result, bacterial infections may become more difficult to treat, requiring higher doses of medication, alternative drugs, or longer treatment courses. In some cases, drug-resistant infections can lead to serious health complications, increased healthcare costs, and higher mortality rates.

Examples of bacterial drug resistance include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and multidrug-resistant tuberculosis (MDR-TB). Preventing the spread of bacterial drug resistance is crucial for maintaining effective treatments for infectious diseases.

Tetracycline is a broad-spectrum antibiotic, which is used to treat various bacterial infections. It works by preventing the growth and multiplication of bacteria. It is a part of the tetracycline class of antibiotics, which also includes doxycycline, minocycline, and others.

Tetracycline is effective against a wide range of gram-positive and gram-negative bacteria, as well as some atypical organisms such as rickettsia, chlamydia, mycoplasma, and spirochetes. It is commonly used to treat respiratory infections, skin infections, urinary tract infections, sexually transmitted diseases, and other bacterial infections.

Tetracycline is available in various forms, including tablets, capsules, and liquid solutions. It should be taken orally with a full glass of water, and it is recommended to take it on an empty stomach, at least one hour before or two hours after meals. The drug can cause tooth discoloration in children under the age of 8, so it is generally not recommended for use in this population.

Like all antibiotics, tetracycline should be used only to treat bacterial infections and not viral infections, such as the common cold or flu. Overuse or misuse of antibiotics can lead to antibiotic resistance, which makes it harder to treat infections in the future.

Streptococcus pyogenes is a Gram-positive, beta-hemolytic streptococcus bacterium that causes various suppurative (pus-forming) and nonsuppurative infections in humans. It is also known as group A Streptococcus (GAS) due to its ability to produce the M protein, which confers type-specific antigenicity and allows for serological classification into more than 200 distinct Lancefield groups.

S. pyogenes is responsible for a wide range of clinical manifestations, including pharyngitis (strep throat), impetigo, cellulitis, erysipelas, scarlet fever, rheumatic fever, and acute poststreptococcal glomerulonephritis. In rare cases, it can lead to invasive diseases such as necrotizing fasciitis (flesh-eating disease) and streptococcal toxic shock syndrome (STSS).

The bacterium is typically transmitted through respiratory droplets or direct contact with infected skin lesions. Effective prevention strategies include good hygiene practices, such as frequent handwashing and avoiding sharing personal items, as well as prompt recognition and treatment of infections to prevent spread.

Streptococcus pneumoniae, also known as the pneumococcus, is a gram-positive, alpha-hemolytic bacterium frequently found in the upper respiratory tract of healthy individuals. It is a leading cause of community-acquired pneumonia and can also cause other infectious diseases such as otitis media (ear infection), sinusitis, meningitis, and bacteremia (bloodstream infection). The bacteria are encapsulated, and there are over 90 serotypes based on variations in the capsular polysaccharide. Some serotypes are more virulent or invasive than others, and the polysaccharide composition is crucial for vaccine development. S. pneumoniae infection can be treated with antibiotics, but the emergence of drug-resistant strains has become a significant global health concern.

Gastrointestinal agents are a class of pharmaceutical drugs that affect the gastrointestinal (GI) tract, which includes the organs involved in digestion such as the mouth, esophagus, stomach, small intestine, large intestine, and anus. These agents can have various effects on the GI tract, including:

1. Increasing gastric motility (promoting bowel movements) - laxatives, prokinetics
2. Decreasing gastric motility (reducing bowel movements) - antidiarrheal agents
3. Neutralizing gastric acid - antacids
4. Reducing gastric acid secretion - H2-blockers, proton pump inhibitors
5. Protecting the mucosal lining of the GI tract - sucralfate, misoprostol
6. Relieving symptoms associated with GI disorders such as bloating, abdominal pain, and nausea - antispasmodics, antiemetics

Examples of gastrointestinal agents include:

* Laxatives (e.g., psyllium, docusate)
* Prokinetics (e.g., metoclopramide)
* Antacids (e.g., calcium carbonate, aluminum hydroxide)
* H2-blockers (e.g., ranitidine, famotidine)
* Proton pump inhibitors (e.g., omeprazole, lansoprazole)
* Sucralfate
* Misoprostol
* Antispasmodics (e.g., hyoscyamine, dicyclomine)
* Antiemetics (e.g., ondansetron, promethazine)

It is important to note that gastrointestinal agents can have both therapeutic and adverse effects, and their use should be based on a careful evaluation of the patient's condition and medical history.

Clarithromycin is a antibiotic medication used to treat various types of bacterial infections, including respiratory, skin, and soft tissue infections. It is a member of the macrolide antibiotic family, which works by inhibiting bacterial protein synthesis. Clarithromycin is available by prescription and is often used in combination with other medications to treat conditions such as Helicobacter pylori infection and Mycobacterium avium complex (MAC) infection.

The medical definition of clarithromycin is:

"A antibiotic medication used to treat various types of bacterial infections, belonging to the macrolide antibiotic family. It works by inhibiting bacterial protein synthesis and is available by prescription."

Streptococcal infections are a type of infection caused by group A Streptococcus bacteria (Streptococcus pyogenes). These bacteria can cause a variety of illnesses, ranging from mild skin infections to serious and potentially life-threatening conditions such as sepsis, pneumonia, and necrotizing fasciitis (flesh-eating disease).

Some common types of streptococcal infections include:

* Streptococcal pharyngitis (strep throat) - an infection of the throat and tonsils that can cause sore throat, fever, and swollen lymph nodes.
* Impetigo - a highly contagious skin infection that causes sores or blisters on the skin.
* Cellulitis - a bacterial infection of the deeper layers of the skin and underlying tissue that can cause redness, swelling, pain, and warmth in the affected area.
* Scarlet fever - a streptococcal infection that causes a bright red rash on the body, high fever, and sore throat.
* Necrotizing fasciitis - a rare but serious bacterial infection that can cause tissue death and destruction of the muscles and fascia (the tissue that covers the muscles).

Treatment for streptococcal infections typically involves antibiotics to kill the bacteria causing the infection. It is important to seek medical attention if you suspect a streptococcal infection, as prompt treatment can help prevent serious complications.

Miacamycin is not a medical term itself, but Miocamycin is a specific type of antibiotic. It belongs to the class of macrolide antibiotics, which are used to treat various bacterial infections. The drug works by inhibiting the growth of bacteria, and it is often used to treat respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted diseases.

Miacamycin may also be referred to as its generic name, miamictin, or its brand name, Viactiv Miacalcin. It's important to note that the use of antibiotics should always be under the guidance and supervision of a healthcare professional, as misuse can lead to antibiotic resistance.

Virginiamycin is not a medical condition or disease, but rather an antibiotic used in veterinary medicine to promote growth and prevent or treat certain bacterial infections in animals, particularly in livestock such as cattle, swine, and poultry. It is a mixture of two components, virginiamycin M1 and virginiamycin S1, which have antibacterial properties against gram-positive bacteria.

Virginiamycin belongs to the streptogramin class of antibiotics and works by binding to the bacterial ribosome, inhibiting protein synthesis and ultimately killing the bacteria. It is not approved for use in humans, except under certain circumstances as part of an investigational new drug (IND) protocol or in specific medical devices.

It's important to note that the use of antibiotics in livestock can contribute to the development of antibiotic-resistant bacteria, which can have negative impacts on human health. Therefore, responsible and judicious use of antibiotics is essential to minimize this risk.

Lincosamides are a class of antibiotics that are structurally related to limcosamine and consist of lincomycin and its derivatives such as clindamycin. They bind to the 50S ribosomal subunit and inhibit bacterial protein synthesis. These antibiotics have a bacteriostatic effect and are primarily used to treat anaerobic infections, as well as some Gram-positive bacterial infections. Common side effects include gastrointestinal symptoms such as diarrhea and nausea. Additionally, lincosamides can cause pseudomembranous colitis, a potentially serious condition caused by the overgrowth of Clostridium difficile bacteria in the gut.

Motilin is a hormone that is produced and released by specialized cells called endocrine cells, which are located in the duodenum, which is the first part of the small intestine. Motilin plays an important role in regulating the movements of the gastrointestinal (GI) tract, also known as peristalsis.

Motilin stimulates the contraction of the smooth muscle in the GI tract, which helps to move food and other contents through the digestive system. It is particularly important for initiating the "housekeeper" wave, also known as the migrating motor complex (MMC), which occurs during periods of fasting and helps to clear out any remaining undigested material from the stomach and small intestine.

Motilin has been studied as a potential target for the treatment of gastroparesis, a condition in which the stomach is unable to empty properly due to weak or abnormal contractions of the smooth muscle. Motilin agonists, which are drugs that bind to and activate motilin receptors, have been shown to improve gastric emptying in some people with gastroparesis.

Oleandomycin is an antibiotic that belongs to the class of macrolides. It is primarily used in veterinary medicine for treating bacterial infections in animals. The drug works by inhibiting protein synthesis in bacteria, which interferes with their growth and multiplication. Oleandomycin is not commonly used in human medicine due to its potential for causing liver toxicity.

Here's a more detailed medical definition of Oleandomycin:

Oleandomycin is a macrolide antibiotic derived from Streptomyces antibioticus. It has a molecular formula of C32H47NO13 and a molecular weight of 659.7 g/mol. The drug is administered orally and has a broad spectrum of activity against gram-positive bacteria, including streptococci, staphylococci, and pneumococci. Oleandomycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, which interferes with peptide bond formation.

While oleandomycin has been used in human medicine in the past, it is not commonly used today due to its potential for causing liver toxicity. It is primarily used in veterinary medicine for treating bacterial infections in animals. Oleandomycin may be used as an alternative antibiotic in cases where other macrolides are not effective or well-tolerated.

It's important to note that the use of any antibiotics, including oleandomycin, should be done under the guidance and supervision of a licensed healthcare provider. Misuse or overuse of antibiotics can lead to antibiotic resistance, which is a significant public health concern.

Penicillins are a group of antibiotics derived from the Penicillium fungus. They are widely used to treat various bacterial infections due to their bactericidal activity, which means they kill bacteria by interfering with the synthesis of their cell walls. The first penicillin, benzylpenicillin (also known as penicillin G), was discovered in 1928 by Sir Alexander Fleming. Since then, numerous semi-synthetic penicillins have been developed to expand the spectrum of activity and stability against bacterial enzymes that can inactivate these drugs.

Penicillins are classified into several groups based on their chemical structure and spectrum of activity:

1. Natural Penicillins (e.g., benzylpenicillin, phenoxymethylpenicillin): These have a narrow spectrum of activity, mainly targeting Gram-positive bacteria such as streptococci and staphylococci. However, they are susceptible to degradation by beta-lactamase enzymes produced by some bacteria.
2. Penicillinase-resistant Penicillins (e.g., methicillin, oxacillin, nafcillin): These penicillins resist degradation by certain bacterial beta-lactamases and are primarily used to treat infections caused by staphylococci, including methicillin-susceptible Staphylococcus aureus (MSSA).
3. Aminopenicillins (e.g., ampicillin, amoxicillin): These penicillins have an extended spectrum of activity compared to natural penicillins, including some Gram-negative bacteria such as Escherichia coli and Haemophilus influenzae. However, they are still susceptible to degradation by many beta-lactamases.
4. Antipseudomonal Penicillins (e.g., carbenicillin, ticarcillin): These penicillins have activity against Pseudomonas aeruginosa and other Gram-negative bacteria with increased resistance to other antibiotics. They are often combined with beta-lactamase inhibitors such as clavulanate or tazobactam to protect them from degradation.
5. Extended-spectrum Penicillins (e.g., piperacillin): These penicillins have a broad spectrum of activity, including many Gram-positive and Gram-negative bacteria. They are often combined with beta-lactamase inhibitors to protect them from degradation.

Penicillins are generally well-tolerated antibiotics; however, they can cause allergic reactions in some individuals, ranging from mild skin rashes to life-threatening anaphylaxis. Cross-reactivity between different penicillin classes and other beta-lactam antibiotics (e.g., cephalosporins) is possible but varies depending on the specific drugs involved.

Chloramphenicol is an antibiotic medication that is used to treat a variety of bacterial infections. It works by inhibiting the ability of bacteria to synthesize proteins, which essential for their growth and survival. This helps to stop the spread of the infection and allows the body's immune system to clear the bacteria from the body.

Chloramphenicol is a broad-spectrum antibiotic, which means that it is effective against many different types of bacteria. It is often used to treat serious infections that have not responded to other antibiotics. However, because of its potential for serious side effects, including bone marrow suppression and gray baby syndrome, chloramphenicol is usually reserved for use in cases where other antibiotics are not effective or are contraindicated.

Chloramphenicol can be given by mouth, injection, or applied directly to the skin in the form of an ointment or cream. It is important to take or use chloramphenicol exactly as directed by a healthcare provider, and to complete the full course of treatment even if symptoms improve before all of the medication has been taken. This helps to ensure that the infection is fully treated and reduces the risk of antibiotic resistance.

Troleandomycin is an antibiotic drug that belongs to the family of macrolides. It is primarily used to treat infections caused by bacteria, particularly those that are resistant to penicillin or other antibiotics. Troleandomycin works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of the bacteria.

The medical definition of Troleandomycin is as follows:

Troleandomycin (INN, USAN, BAN), also known as Troidemycin, is a macrolide antibiotic with a chemical formula of (3R,5S,8R,9S,11R,12S,13S,15R,16R,17R,19E,21E,23E)-3-[(2R,4R,5S,6S)-4-dimethylamino-5-hydroxy-6-methyloxan-2-yl]oxy-15-{[2-(2-methoxyethoxy)ethoxy]methyl}-8-{(1E,3S)-3-[2-(2-methoxyethoxy)ethoxy]prop-1-enyl}-9,11,13-trihydroxy-17-(2-hydroxyethyl)-19,21,23-nonatriene-2,4,6,10,14,16,18-heptaone.

Troleandomycin is used to treat a variety of bacterial infections, including respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases. It is also used to prevent endocarditis (inflammation of the lining of the heart) in patients with certain heart conditions who are undergoing dental or surgical procedures.

Like other macrolide antibiotics, Troleandomycin may cause gastrointestinal side effects such as nausea, vomiting, and diarrhea. It may also interact with other medications, including warfarin, oral contraceptives, and digoxin, leading to potentially serious adverse effects. Therefore, it is important to inform healthcare providers of all medications being taken before starting Troleandomycin therapy.

'Campylobacter coli' is a species of bacteria that can cause gastrointestinal illness in humans. It is one of the several species within the genus Campylobacter, which are gram-negative, microaerophilic, spiral or curved rods. 'Campylobacter coli' is commonly found in the intestines of animals, particularly swine and cattle, and can be transmitted to humans through contaminated food or water.

The most common symptom of infection with 'Campylobacter coli' is diarrhea, which can range from mild to severe and may be accompanied by abdominal cramps, fever, nausea, and vomiting. The illness, known as campylobacteriosis, typically lasts for about a week and resolves on its own without specific treatment in most cases. However, in some cases, the infection can lead to more serious complications, such as bacteremia (bacterial infection of the blood) or Guillain-Barré syndrome, a rare neurological disorder that can cause muscle weakness and paralysis.

Prevention measures include cooking food thoroughly, washing hands and surfaces frequently, and avoiding cross-contamination between raw and cooked foods. 'Campylobacter coli' infections are also reportable to public health authorities in many jurisdictions, as they are considered a significant cause of foodborne illness worldwide.

Tetracycline resistance is a type of antibiotic resistance where bacteria have developed the ability to survive and grow in the presence of tetracyclines, a class of antibiotics used to treat a wide range of bacterial infections. This resistance can be mediated through various mechanisms such as:

1. Efflux pumps: These are proteins that actively pump tetracyclines out of the bacterial cell, reducing the intracellular concentration of the antibiotic and preventing it from reaching its target site.
2. Ribosomal protection proteins (RPPs): These proteins bind to the ribosomes (the sites of protein synthesis) and prevent tetracyclines from binding, thus allowing protein synthesis to continue in the presence of the antibiotic.
3. Enzymatic modification: Some bacteria produce enzymes that modify tetracyclines, rendering them ineffective or less effective against bacterial growth.
4. Mutations in target sites: Bacteria can also acquire mutations in their genome that alter the structure of the target site (ribosomes), preventing tetracyclines from binding and inhibiting protein synthesis.

Tetracycline resistance has become a significant public health concern, as it limits the therapeutic options for treating bacterial infections and contributes to the emergence and spread of multidrug-resistant bacteria. The primary causes of tetracycline resistance include the misuse and overuse of antibiotics in both human medicine and agriculture.

Gastric emptying is the process by which the stomach empties its contents into the small intestine. In medical terms, it refers to the rate and amount of food that leaves the stomach and enters the duodenum, which is the first part of the small intestine. This process is regulated by several factors, including the volume and composition of the meal, hormonal signals, and neural mechanisms. Abnormalities in gastric emptying can lead to various gastrointestinal symptoms and disorders, such as gastroparesis, where the stomach's ability to empty food is delayed.

Penicillin resistance is the ability of certain bacteria to withstand the antibacterial effects of penicillin, a type of antibiotic. This occurs when these bacteria have developed mechanisms that prevent penicillin from binding to and inhibiting the function of their cell wall biosynthesis proteins, particularly the enzyme transpeptidase.

One common mechanism of penicillin resistance is the production of beta-lactamases, enzymes that can hydrolyze and inactivate the beta-lactam ring structure present in penicillin and other related antibiotics. Another mechanism involves alterations in the bacterial cell wall that prevent penicillin from binding to its target proteins.

Penicillin resistance is a significant concern in clinical settings, as it can limit treatment options for bacterial infections and may necessitate the use of more potent or toxic antibiotics. It is important to note that misuse or overuse of antibiotics can contribute to the development and spread of antibiotic-resistant bacteria, including those resistant to penicillin.

Methyltransferases are a class of enzymes that catalyze the transfer of a methyl group (-CH3) from a donor molecule to an acceptor molecule, which is often a protein, DNA, or RNA. This transfer of a methyl group can modify the chemical and physical properties of the acceptor molecule, playing a crucial role in various cellular processes such as gene expression, signal transduction, and DNA repair.

In biochemistry, methyltransferases are classified based on the type of donor molecule they use for the transfer of the methyl group. The most common methyl donor is S-adenosylmethionine (SAM), a universal methyl group donor found in many organisms. Methyltransferases that utilize SAM as a cofactor are called SAM-dependent methyltransferases.

Abnormal regulation or function of methyltransferases has been implicated in several diseases, including cancer and neurological disorders. Therefore, understanding the structure, function, and regulation of these enzymes is essential for developing targeted therapies to treat these conditions.

Pneumococcal infections are illnesses caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium can infect different parts of the body, including the lungs (pneumonia), blood (bacteremia or sepsis), and the covering of the brain and spinal cord (meningitis). Pneumococcal infections can also cause ear infections and sinus infections. The bacteria spread through close contact with an infected person, who may spread the bacteria by coughing or sneezing. People with weakened immune systems, children under 2 years of age, adults over 65, and those with certain medical conditions are at increased risk for developing pneumococcal infections.

Streptococcus is a genus of Gram-positive, spherical bacteria that typically form pairs or chains when clustered together. These bacteria are facultative anaerobes, meaning they can grow in the presence or absence of oxygen. They are non-motile and do not produce spores.

Streptococcus species are commonly found on the skin and mucous membranes of humans and animals. Some strains are part of the normal flora of the body, while others can cause a variety of infections, ranging from mild skin infections to severe and life-threatening diseases such as sepsis, meningitis, and toxic shock syndrome.

The pathogenicity of Streptococcus species depends on various virulence factors, including the production of enzymes and toxins that damage tissues and evade the host's immune response. One of the most well-known Streptococcus species is Streptococcus pyogenes, also known as group A streptococcus (GAS), which is responsible for a wide range of clinical manifestations, including pharyngitis (strep throat), impetigo, cellulitis, necrotizing fasciitis, and rheumatic fever.

It's important to note that the classification of Streptococcus species has evolved over time, with many former members now classified as different genera within the family Streptococcaceae. The current classification system is based on a combination of phenotypic characteristics (such as hemolysis patterns and sugar fermentation) and genotypic methods (such as 16S rRNA sequencing and multilocus sequence typing).

Staphylococcus is a genus of Gram-positive, facultatively anaerobic bacteria that are commonly found on the skin and mucous membranes of humans and other animals. Many species of Staphylococcus can cause infections in humans, but the most notable is Staphylococcus aureus, which is responsible for a wide range of illnesses, from minor skin infections to life-threatening conditions such as pneumonia, endocarditis, and sepsis.

Staphylococcus species are non-motile, non-spore forming, and typically occur in grape-like clusters when viewed under a microscope. They can be coagulase-positive or coagulase-negative, with S. aureus being the most well-known coagulase-positive species. Coagulase is an enzyme that causes the clotting of plasma, and its presence is often used to differentiate S. aureus from other Staphylococcus species.

These bacteria are resistant to many commonly used antibiotics, including penicillin, due to the production of beta-lactamases. Methicillin-resistant Staphylococcus aureus (MRSA) is a particularly problematic strain that has developed resistance to multiple antibiotics and can cause severe, difficult-to-treat infections.

Proper hand hygiene, use of personal protective equipment, and environmental cleaning are crucial measures for preventing the spread of Staphylococcus in healthcare settings and the community.

Staphylococcus aureus is a type of gram-positive, round (coccal) bacterium that is commonly found on the skin and mucous membranes of warm-blooded animals and humans. It is a facultative anaerobe, which means it can grow in the presence or absence of oxygen.

Staphylococcus aureus is known to cause a wide range of infections, from mild skin infections such as pimples, impetigo, and furuncles (boils) to more severe and potentially life-threatening infections such as pneumonia, endocarditis, osteomyelitis, and sepsis. It can also cause food poisoning and toxic shock syndrome.

The bacterium is often resistant to multiple antibiotics, including methicillin, which has led to the emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains that are difficult to treat. Proper hand hygiene and infection control practices are critical in preventing the spread of Staphylococcus aureus and MRSA.

Multiple bacterial drug resistance (MDR) is a medical term that refers to the resistance of multiple strains of bacteria to several antibiotics or antimicrobial agents. This means that these bacteria have developed mechanisms that enable them to survive and multiply despite being exposed to drugs that were previously effective in treating infections caused by them.

MDR is a significant public health concern because it limits the treatment options available for bacterial infections, making them more difficult and expensive to treat. In some cases, MDR bacteria may cause severe or life-threatening infections that are resistant to all available antibiotics, leaving doctors with few or no effective therapeutic options.

MDR can arise due to various mechanisms, including the production of enzymes that inactivate antibiotics, changes in bacterial cell membrane permeability that prevent antibiotics from entering the bacteria, and the development of efflux pumps that expel antibiotics out of the bacteria. The misuse or overuse of antibiotics is a significant contributor to the emergence and spread of MDR bacteria.

Preventing and controlling the spread of MDR bacteria requires a multifaceted approach, including the judicious use of antibiotics, infection control measures, surveillance, and research into new antimicrobial agents.

Bacterial DNA refers to the genetic material found in bacteria. It is composed of a double-stranded helix containing four nucleotide bases - adenine (A), thymine (T), guanine (G), and cytosine (C) - that are linked together by phosphodiester bonds. The sequence of these bases in the DNA molecule carries the genetic information necessary for the growth, development, and reproduction of bacteria.

Bacterial DNA is circular in most bacterial species, although some have linear chromosomes. In addition to the main chromosome, many bacteria also contain small circular pieces of DNA called plasmids that can carry additional genes and provide resistance to antibiotics or other environmental stressors.

Unlike eukaryotic cells, which have their DNA enclosed within a nucleus, bacterial DNA is present in the cytoplasm of the cell, where it is in direct contact with the cell's metabolic machinery. This allows for rapid gene expression and regulation in response to changing environmental conditions.

Anti-infective agents are a class of medications that are used to treat infections caused by various microorganisms such as bacteria, viruses, fungi, and parasites. These agents work by either killing the microorganism or inhibiting its growth, thereby helping to control the infection and alleviate symptoms.

There are several types of anti-infective agents, including:

1. Antibiotics: These are medications that are used to treat bacterial infections. They work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic).
2. Antivirals: These are medications that are used to treat viral infections. They work by interfering with the replication of the virus, preventing it from spreading and causing further damage.
3. Antifungals: These are medications that are used to treat fungal infections. They work by disrupting the cell membrane of the fungus, killing it or inhibiting its growth.
4. Antiparasitics: These are medications that are used to treat parasitic infections. They work by either killing the parasite or inhibiting its growth and reproduction.

It is important to note that anti-infective agents are not effective against all types of infections, and it is essential to use them appropriately to avoid the development of drug-resistant strains of microorganisms.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

23S Ribosomal RNA (rRNA) is a type of rRNA that is a component of the large ribosomal subunit in both prokaryotic and eukaryotic cells. In prokaryotes, the large ribosomal subunit contains 50S, which consists of 23S rRNA, 5S rRNA, and around 33 proteins. The 23S rRNA plays a crucial role in the decoding of mRNA during protein synthesis and also participates in the formation of the peptidyl transferase center, where peptide bonds are formed between amino acids.

The 23S rRNA is a long RNA molecule that contains both coding and non-coding regions. It has a complex secondary structure, which includes several domains and subdomains, as well as numerous stem-loop structures. These structures are important for the proper functioning of the ribosome during protein synthesis.

In addition to its role in protein synthesis, 23S rRNA has been used as a target for antibiotics that inhibit bacterial growth. For example, certain antibiotics bind to specific regions of the 23S rRNA and interfere with the function of the ribosome, thereby preventing bacterial protein synthesis and growth. However, because eukaryotic cells do not have a 23S rRNA equivalent, these antibiotics are generally not toxic to human cells.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

Penicillin G is a type of antibiotic that belongs to the class of medications called penicillins. It is a natural antibiotic derived from the Penicillium fungus and is commonly used to treat a variety of bacterial infections. Penicillin G is active against many gram-positive bacteria, as well as some gram-negative bacteria.

Penicillin G is available in various forms, including an injectable solution and a powder for reconstitution into a solution. It works by interfering with the ability of bacteria to form a cell wall, which ultimately leads to bacterial death. Penicillin G is often used to treat serious infections that cannot be treated with other antibiotics, such as endocarditis (inflammation of the inner lining of the heart), pneumonia, and meningitis (inflammation of the membranes surrounding the brain and spinal cord).

It's important to note that Penicillin G is not commonly used for topical or oral treatment due to its poor absorption in the gastrointestinal tract and instability in acidic environments. Additionally, as with all antibiotics, Penicillin G should be used under the guidance of a healthcare professional to ensure appropriate use and to reduce the risk of antibiotic resistance.

Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is a type of bacteria that commonly colonizes the gastrointestinal and genitourinary tracts of humans. It is Gram-positive, facultatively anaerobic, and forms chains when viewed under the microscope.

While S. agalactiae can be carried asymptomatically by many adults, it can cause serious infections in newborns, pregnant women, elderly individuals, and people with weakened immune systems. In newborns, GBS can lead to sepsis, pneumonia, and meningitis, which can result in long-term health complications or even be fatal if left untreated.

Pregnant women are often screened for GBS colonization during the third trimester of pregnancy, and those who test positive may receive intrapartum antibiotics to reduce the risk of transmission to their newborns during delivery.

Legionella is the genus of gram-negative, aerobic bacteria that can cause serious lung infections known as legionellosis. The most common species causing disease in humans is Legionella pneumophila. These bacteria are widely found in natural freshwater environments such as lakes and streams. However, they can also be found in man-made water systems like cooling towers, hot tubs, decorative fountains, and plumbing systems. When people breathe in small droplets of water containing the bacteria, especially in the form of aerosols or mist, they may develop Legionnaires' disease, a severe form of pneumonia, or Pontiac fever, a milder flu-like illness. The risk of infection increases in individuals with weakened immune systems, chronic lung diseases, older age, and smokers. Appropriate disinfection methods and regular maintenance of water systems can help prevent the growth and spread of Legionella bacteria.

Cytochrome P-450 CYP3A is a subfamily of the cytochrome P-450 enzyme superfamily, which are primarily involved in drug metabolism in the human body. These enzymes are found predominantly in the liver, but also in other tissues such as the small intestine, kidneys, and brain.

CYP3A enzymes are responsible for metabolizing a wide variety of drugs, including many statins, benzodiazepines, antidepressants, and opioids. They can also metabolize endogenous compounds such as steroids and bile acids. The activity of CYP3A enzymes can be influenced by various factors, including genetic polymorphisms, age, sex, pregnancy, and the presence of other drugs or diseases.

The name "cytochrome P-450" refers to the fact that these enzymes contain a heme group that absorbs light at a wavelength of 450 nanometers when it is complexed with carbon monoxide. The term "CYP3A" denotes the specific subfamily of cytochrome P-450 enzymes that share a high degree of sequence similarity and function.

'Campylobacter' is a genus of gram-negative, spiral-shaped bacteria that are commonly found in the intestinal tracts of animals, including birds and mammals. These bacteria are a leading cause of bacterial foodborne illness worldwide, with Campylobacter jejuni being the most frequently identified species associated with human infection.

Campylobacter infection, also known as campylobacteriosis, typically causes symptoms such as diarrhea (often bloody), abdominal cramps, fever, and vomiting. The infection is usually acquired through the consumption of contaminated food or water, particularly undercooked poultry, raw milk, and contaminated produce. It can also be transmitted through contact with infected animals or their feces.

While most cases of campylobacteriosis are self-limiting and resolve within a week without specific treatment, severe or prolonged infections may require antibiotic therapy. In rare cases, Campylobacter infection can lead to serious complications such as bacteremia (bacterial bloodstream infection), meningitis, or Guillain-Barré syndrome, a neurological disorder that can cause muscle weakness and paralysis.

Preventive measures include proper food handling and cooking techniques, thorough handwashing, and avoiding cross-contamination between raw and cooked foods.

Tylosin is defined as a macrolide antibiotic produced by the bacterium Streptomyces fradiae. It is primarily used in veterinary medicine to treat various bacterial infections in animals, such as respiratory and digestive tract infections caused by susceptible organisms.

Tylosin works by binding to the 50S subunit of the bacterial ribosome, inhibiting protein synthesis and thereby preventing bacterial growth. It has a broad spectrum of activity against gram-positive bacteria, including some strains that are resistant to other antibiotics. However, tylosin is not commonly used in human medicine due to its potential for causing hearing damage and other side effects.

In addition to its use as an antibiotic, tylosin has also been used as a growth promoter in animal feed to improve feed efficiency and weight gain. However, this practice has been banned in some countries due to concerns about the development of antibiotic resistance and the potential risks to human health.

In the context of medical laboratory reporting, "R factors" refer to a set of values that describe the resistance of certain bacteria to different antibiotics. These factors are typically reported as R1, R2, R3, and so on, where each R factor corresponds to a specific antibiotic or class of antibiotics.

An R factor value of "1" indicates susceptibility to the corresponding antibiotic, while an R factor value of "R" (or "R-", depending on the laboratory's reporting practices) indicates resistance. An intermediate category may also be reported as "I" or "I-", indicating that the bacterium is intermediately sensitive to the antibiotic in question.

It's important to note that R factors are just one piece of information used to guide clinical decision-making around antibiotic therapy, and should be interpreted in conjunction with other factors such as the patient's clinical presentation, the severity of their infection, and any relevant guidelines or recommendations from infectious disease specialists.

Ribosomes are complex macromolecular structures composed of ribonucleic acid (RNA) and proteins that play a crucial role in protein synthesis within cells. They serve as the site for translation, where messenger RNA (mRNA) is translated into a specific sequence of amino acids to create a polypeptide chain, which eventually folds into a functional protein.

Ribosomes consist of two subunits: a smaller subunit and a larger subunit. These subunits are composed of ribosomal RNA (rRNA) molecules and proteins. In eukaryotic cells, the smaller subunit is denoted as the 40S subunit, while the larger subunit is referred to as the 60S subunit. In prokaryotic cells, these subunits are named the 30S and 50S subunits, respectively. The ribosome's overall structure resembles a "doughnut" or a "cotton reel," with grooves and binding sites for various factors involved in protein synthesis.

Ribosomes can be found floating freely within the cytoplasm of cells or attached to the endoplasmic reticulum (ER) membrane, forming part of the rough ER. Membrane-bound ribosomes are responsible for synthesizing proteins that will be transported across the ER and ultimately secreted from the cell or inserted into the membrane. In contrast, cytoplasmic ribosomes synthesize proteins destined for use within the cytoplasm or organelles.

In summary, ribosomes are essential components of cells that facilitate protein synthesis by translating mRNA into functional polypeptide chains. They can be found in various cellular locations and exist as either free-floating entities or membrane-bound structures.

Staphylococcal infections are a type of infection caused by Staphylococcus bacteria, which are commonly found on the skin and nose of healthy people. However, if they enter the body through a cut, scratch, or other wound, they can cause an infection.

There are several types of Staphylococcus bacteria, but the most common one that causes infections is Staphylococcus aureus. These infections can range from minor skin infections such as pimples, boils, and impetigo to serious conditions such as pneumonia, bloodstream infections, and toxic shock syndrome.

Symptoms of staphylococcal infections depend on the type and severity of the infection. Treatment typically involves antibiotics, either topical or oral, depending on the severity and location of the infection. In some cases, hospitalization may be necessary for more severe infections. It is important to note that some strains of Staphylococcus aureus have developed resistance to certain antibiotics, making them more difficult to treat.

Gastrointestinal motility refers to the coordinated muscular contractions and relaxations that propel food, digestive enzymes, and waste products through the gastrointestinal tract. This process involves the movement of food from the mouth through the esophagus into the stomach, where it is mixed with digestive enzymes and acids to break down food particles.

The contents are then emptied into the small intestine, where nutrients are absorbed, and the remaining waste products are moved into the large intestine for further absorption of water and electrolytes and eventual elimination through the rectum and anus.

Gastrointestinal motility is controlled by a complex interplay between the autonomic nervous system, hormones, and local reflexes. Abnormalities in gastrointestinal motility can lead to various symptoms such as bloating, abdominal pain, nausea, vomiting, diarrhea, or constipation.

Enterococcus faecalis is a species of gram-positive, facultatively anaerobic bacteria that are part of the normal gut microbiota in humans and animals. It is a type of enterococci that can cause a variety of infections, including urinary tract infections, bacteremia, endocarditis, and meningitis, particularly in hospitalized patients or those with compromised immune systems.

E. faecalis is known for its ability to survive in a wide range of environments and resist various antibiotics, making it difficult to treat infections caused by this organism. It can also form biofilms, which further increase its resistance to antimicrobial agents and host immune responses. Accurate identification and appropriate treatment of E. faecalis infections are essential to prevent complications and ensure positive patient outcomes.

'Campylobacter jejuni' is a gram-negative, spiral-shaped bacterium that is a common cause of foodborne illness worldwide. It is often found in the intestines of warm-blooded animals, including birds and mammals, and can be transmitted to humans through contaminated food or water.

The bacteria are capable of causing an infection known as campylobacteriosis, which is characterized by symptoms such as diarrhea, abdominal cramps, fever, and vomiting. In severe cases, the infection can spread to the bloodstream and cause serious complications, particularly in individuals with weakened immune systems.

'Campylobacter jejuni' is one of the most common causes of foodborne illness in the United States, with an estimated 1.3 million cases occurring each year. It is often found in undercooked poultry and raw or unpasteurized milk products, as well as in contaminated water supplies. Proper cooking and pasteurization can help reduce the risk of infection, as can good hygiene practices such as washing hands thoroughly after handling raw meat and vegetables.

Serotyping is a laboratory technique used to classify microorganisms, such as bacteria and viruses, based on the specific antigens or proteins present on their surface. It involves treating the microorganism with different types of antibodies and observing which ones bind to its surface. Each distinct set of antigens corresponds to a specific serotype, allowing for precise identification and characterization of the microorganism. This technique is particularly useful in epidemiology, vaccine development, and infection control.

Ofloxacin is an antibacterial drug, specifically a fluoroquinolone. It works by inhibiting the bacterial DNA gyrase, which is essential for the bacteria to replicate. This results in the death of the bacteria and helps to stop the infection. Ofloxacin is used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and sexually transmitted diseases. It is available in various forms, such as tablets, capsules, and eye drops. As with any medication, it should be used only under the direction of a healthcare professional, and its use may be associated with certain risks and side effects.

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

Genetic conjugation is a type of genetic transfer that occurs between bacterial cells. It involves the process of one bacterium (the donor) transferring a piece of its DNA to another bacterium (the recipient) through direct contact or via a bridge-like connection called a pilus. This transferred DNA may contain genes that provide the recipient cell with new traits, such as antibiotic resistance or virulence factors, which can make the bacteria more harmful or difficult to treat. Genetic conjugation is an important mechanism for the spread of antibiotic resistance and other traits among bacterial populations.

Pharyngitis is the medical term for inflammation of the pharynx, which is the back portion of the throat. This condition is often characterized by symptoms such as sore throat, difficulty swallowing, and scratchiness in the throat. Pharyngitis can be caused by a variety of factors, including viral infections (such as the common cold), bacterial infections (such as strep throat), and irritants (such as smoke or chemical fumes). Treatment for pharyngitis depends on the underlying cause of the condition, but may include medications to relieve symptoms or antibiotics to treat a bacterial infection.

Legionnaires' disease is a severe and often lethal form of pneumonia, a lung infection, caused by the bacterium Legionella pneumophila. It's typically contracted by inhaling microscopic water droplets containing the bacteria, which can be found in various environmental sources like cooling towers, hot tubs, whirlpools, decorative fountains, and large plumbing systems. The disease is not transmitted through person-to-person contact. Symptoms usually appear within 2-10 days after exposure and may include cough, fever, chills, muscle aches, headache, and shortness of breath. Some individuals, particularly those with weakened immune systems, elderly people, and smokers, are at higher risk for developing Legionnaires' disease. Early diagnosis and appropriate antibiotic treatment can improve the chances of recovery. Preventive measures include regular testing and maintenance of potential sources of Legionella bacteria in buildings and other facilities.

... A has been found to have the most antibacterial activity, followed by erythromycin B. Erythromycins C and D are ... The following erythromycin combinations are available for oral dosage: erythromycin base (capsules, tablets) erythromycin ... erythromycin gluceptate erythromycin lactobionate For ophthalmic use: erythromycin base (ointment) Gastrointestinal ... Standard-grade erythromycin is primarily composed of four related compounds known as erythromycins A, B, C, and D. Each of ...
... (EC 1.14.13.154, EryK) is an enzyme with systematic name erythromycin-D,NADPH:oxygen oxidoreductase ... erythromycin C + NADP+ + H2O Erythromycin 12 hydroxylase is responsible for the C-12 hydroxylation of the macrolactone ring. ... Erythromycin+12+hydroxylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology v t e ( ... Lambalot RH, Cane DE, Aparicio JJ, Katz L (February 1995). "Overproduction and characterization of the erythromycin C-12 ...
The erythromycin breath test (ERMBT) is a method used to measure metabolism (oxidation and elimination from the system) by a ... Erythromycin is tagged with carbon-14 and given as an intravenous injection; after 20 minutes the subject blows up a balloon ... Erythromycin produces 14CO2, and this 14CO2 can be measured to study drugs that interact with the cytochrome P450 system. ... Erythromycin is a drug that treats bacterial infections like bronchitis, sexually transmitted diseases, and pneumonia. The ...
... erythromycin B The enzyme methylates the 3 position of the mycarosyl moiety of erythromycin C. Paulus TJ, Tuan JS, Luebke VE, ... erythromycin A (2) S-adenosyl-L-methionine + erythromycin D ⇌ {\displaystyle \rightleftharpoons } S-adenosyl-L-homocysteine + ... Erythromycin+3''-O-methyltransferase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology v ... Erythromycin 3''-O-methyltransferase (EC 2.1.1.254, EryG) is an enzyme with systematic name S-adenosyl-L-methionine: ...
"ERYTHROMYCIN". Br Med J. 2 (4793): 1085-6. November 1952. doi:10.1136/bmj.2.4793.1085. PMC 2022076. PMID 12987755. Anderson, ... erythromycin (discovered at Eli Lilly and Co.) and their extension to an increasingly wide range of bacterial pathogens. ...
Eli Lilly marketed Erythromycin under the brand name Ilosone. Unfortunately, Aguilar received no credit or compensation for his ... Abelardo Aguilar isolated a strain of bacteria which lead to the development of Erythromycin, a broad-spectrum antibiotic used ... In 1949, Aguilar was testing soil samples from his backyard and had discovered a method to formulate Erythromycin. ... Shah, Falguni (1 April 1998). "Erythromycin". Pediatrics in Review. 19 (4): 140-141. doi:10.1542/pir.19-4-140. ISSN 0191-9601. ...
Erythromycin-based medications can also be used. A single study suggests superiority of azithromycin over doxycycline. Another ... "Erythromycin" (PDF). Davis. 2017. Archived from the original (PDF) on 2017-09-10. Retrieved March 24, 2017. "Pelvic ...
Erythromycin, Saccharopolyspora erythraea. Nystatin, from Streptomyces noursei. Rifamycin, from Amycolatopsis rifamycinica. ...
Erythromycin is similar. A 4.8% tranexamic acid solution is sometimes used as an antifibrinolytic mouthwash to prevent bleeding ...
... produces erythromycin. Miller, E. S.; Woese, C. R.; Brenner, S. (1 July 1991). "Description of the ... Harrell, Erin A.; Miller, Eric S. (21 April 2016). "Genome Sequence of Aeromicrobium erythreum NRRL B-3381, an Erythromycin- ... "Engineering precursor flow for increased erythromycin production in Aeromicrobium erythreum". Metabolic Engineering. 6 (4): 300 ... Erythromycin-Producing Bacterium Arthrobacter sp. Strain NRRL B-3381 as Aeromicrobium erythreum gen. nov., sp. nov". ...
... erythromycin precursor synthase) show only a 45% common identity. Note that unlike in the erythromycin precursor synthase, ... Like erythromycin, oleandomycin binds to the 50s subunit of bacterial ribosomes, inhibiting the completion of proteins vital to ... It is weaker than erythromycin. It used to be sold under the brand name Sigmamycine, combined with tetracycline, and made by ... This macrolide was discovered at around the same time as its relatives erythromycin and spiramycin. Public interest in ...
Erythromycin may be an alternative. Imipenem/cilastatin is an alternative for complicated intraabdominal infections and high- ... Mumps vaccine Varicella vaccine Neostigmine Suxamethonium Vecuronium Pyridostigmineα Aciclovir Azithromycin Erythromycin ...
Antibiotics, e.g. erythromycin, rifampicin. Ergot derivatives used to treat migraine or Parkinson's disease may cause an ...
Weisblum, B (March 1995). "Erythromycin resistance by ribosome modification". Antimicrobial Agents and Chemotherapy. 39 (3): ... or erythromycin ribosome methylase family of genes. Nearly 40 erm genes have been reported to date, which are transferred ...
"Asymmetric total synthesis of erythromycin. 3. Total synthesis of erythromycin". Journal of the American Chemical Society. 103 ... Notable work during his postdoctoral career includes the total synthesis of erythromycin. RajanBabu was a Member of Research ...
Human studies are planned for erythromycin. Erythromycin has been used successfully in patients with gastric issues. "myotonic ... A recent study in December 2015 showed that a common FDA approved antibiotic, Erythromycin reduced myotonia in mice. ... Nakamori M, Taylor K, Mochizuki H, Sobczak K, Takahashi MP (January 2016). "Oral administration of erythromycin decreases RNA ...
These include tetracycline, doxycycline, and erythromycin. Erythromycin may be used as a cream. Doxycycline is most often the ...
Occasionally erythromycin ophthalmic ointment is recommended. Other antibiotics, such as chloramphenicol or amoxicillin may ...
Erythromycin has an advantage over metoclopramide in gastric emptying due to lack of central nervous system side-effects. It is ... Erythromycin and related antibiotics act as non-peptide motilin agonists, and are sometimes used for their ability to stimulate ... In the case of erythromycin, it is its hemiketal intermediate, formed after an oral dose in the low-pH environment of the ... However, some of erythromycin's properties, including antibiotic activity, are not appropriate for a drug designed for chronic ...
The first macrolide discovered was erythromycin, which was first used in 1952. Erythromycin was widely used as a substitute to ... Macrolides, mainly erythromycin and clarithromycin, also have a class effect of QT prolongation, which can lead to torsades de ... The macrolide antibiotics erythromycin, clarithromycin, and roxithromycin have proven to be an effective long-term treatment ... In infants the use of erythromycin has been associated with pyloric stenosis. Some macrolides are also known to cause ...
... the antibiotics erythromycin, clarithromycin, or telithromycin; HIV protease inhibitors; the antidepressant nefazodone; the ...
... erythromycin Mycoplasma pneumoniae - erythromycin Coxiella burnetti - doxycycline Legionella pneumophila - erythromycin, with ... Streptococcus pneumoniae - amoxicillin (or erythromycin in patients allergic to penicillin); cefuroxime and erythromycin in ...
... erythromycin has been shown to cause both QT prolongation and TdP. Erythromycin works inhibiting the CYP3A protein. Patients ... Macrolides Azithromycin Clarithromycin Erythromycin When taken independently, ...
Unlike erythromycin, telithromycin is acid-stable and can therefore be taken orally while being protected from gastric acids. ... Telithromycin is a semi-synthetic erythromycin derivative. It is created by substituting a ketogroup for the cladinose sugar ... Telithromycin has over 10 times higher affinity to the subunit 50S than erythromycin. In addition, telithromycin strongly bind ...
... produces nonactin, erythromycin and werramycine. List of Streptomyces species LPSN bacterio.net ... "Isolation and partial purification of erythromycin from alkaliphilic Streptomyces werraensis isolated from Rajkot, India". ... "Isolation and partial purification of erythromycin from alkaliphilic Streptomyces werraensis isolated from Rajkot, India". ...
C. hominis is often resistant to erythromycin. Since cefotaxime use may be not appropriate for C. hominis endocarditis, an ...
Erythromycin and Other Antibiotics, 303 pages, 1960. Centre for Transformative Innovation, Swinburne University of Technology ...
US 4382086, Sciavolino, Frank C. & Hauske, James R., "9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin ... Diethyl carbonate is used as a solvent such as in erythromycin intramuscular injections. It can be used as a component of ... Anderson, Robert C.; Harris, Paul N.; Chen, K. K. (1955). "Further toxicological studies with ilotycin® (Erythromycin, Lilly ... US 4363803, Hauske, James R., "3",4"-Oxyallylene erythromycin and oleandomycin, composition and method of use", published 1982- ...
Schachner, L.; Eaglstein, W.; Kittles, C.; Mertz, P. (1990). "Topical erythromycin and zinc therapy for acne". Journal of the ... or combined with an antibiotic such as erythromycin for the topical treatment of acne. It is commonly sold as a topical anti- ...
... is a topical gel containing of 5% benzoyl peroxide and 3% erythromycin. Its main usage is to fight acne. Benzamycin ... "Benzamycin® Topical Gel (erythromycin-benzoyl peroxide gel)". dailymed.nlm.nih.gov. Retrieved 2022-09-21. "Benzamycin ( ... ATRX) Receives FDA Approval For Erythromycin/Benzoyl Peroxide", Biospace.com, 10/19/2005 (Wikipedia articles in need of ... Erythromycin): Uses, Dosage, Side Effects, Interactions, Warning". RxList. Retrieved 2022-09-21. "CIBC World Upgrades Atrix ...

No FAQ available that match "erythromycin"

No images available that match "erythromycin"